Polyanionic Drugs and Viral Oncogenesis: a Novel Approach to Control Infection, Tumor-associated Inflammation and Angiogenesis
Open Access
- 6 November 2008
- Vol. 13 (11) , 2758-2785
Abstract
Polyanionic macromolecules are extremely abundant both in the extracellular environment and inside the cell, where they are readily accessible to many proteins for interactions that play a variety of biological roles. Among polyanions, heparin, heparan sulfate proteoglycans (HSPGs) and glycosphingolipids (GSLs) are widely distributed in biological fluids, at the cell membrane and inside the cell, where they are implicated in several physiological and/or pathological processes such as infectious diseases, angiogenesis and tumor growth. At a molecular level, these processes are mainly mediated by microbial proteins, cytokines and receptors that exert their functions by binding to HSPGs and/or GSLs, suggesting the possibility to use polyanionic antagonists as efficient drugs for the treatment of infectious diseases and cancer. Polysulfated (PS) or polysulfonated (PSN) compounds are a heterogeneous group of natural, semi-synthetic or synthetic molecules whose prototypes are heparin and suramin. Different structural features confer to PS/PSN compounds the capacity to bind and inhibit the biological activities of those same heparin-binding proteins implicated in infectious diseases and cancer. In this review we will discuss the state of the art and the possible future development of polyanionic drugs in the treatment of infectious diseases and cancer.Keywords
This publication has 228 references indexed in Scilit:
- Sulfated K5 Escherichia coli Polysaccharide Derivatives as Wide-Range Inhibitors of Genital Types of Human PapillomavirusAntimicrobial Agents and Chemotherapy, 2008
- An Ectromelia Virus Protein That Interacts with Chemokines through Their Glycosaminoglycan Binding DomainJournal of Virology, 2008
- Sucrose octasulfate regulates fibroblast growth factor‐2 binding, transport, and activity: Potential for regulation of tumor growthJournal of Cellular Physiology, 2007
- Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycansHepatology, 2007
- Heparin-mimetic sulfated peptides with modulated affinities for heparin-binding peptides and growth factorsPeptides, 2007
- Heparin-Mimicking Sulfonic Acid Polymers as Multitarget Inhibitors of Human Immunodeficiency Virus Type 1 Tat and gp120 ProteinsAntimicrobial Agents and Chemotherapy, 2007
- Sulfated Homologues of Heparin Inhibit Hepatitis C Virus Entry into Mammalian CellsJournal of Virology, 2007
- Inhibition ofPlasmodium falciparumGrowth In Vitro and Adhesion to Chondroitin-4-Sulfate by the Heparan Sulfate Mimetic PI-88 and Other Sulfated OligosaccharidesAntimicrobial Agents and Chemotherapy, 2006
- Interactions between heparan sulfate and proteins: the concept of specificityJournal of Cell Biology, 2006
- Heparan sulfate proteoglycans mediate Staphylococcus aureus interactions with intestinal epitheliumMedical Microbiology and Immunology, 2005